Isolation of novel AAV's and uses thereof
US9596835B2 · kind B2 · utility
59Cited by
29References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2015 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | Nov 13, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/102
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention in some aspects relates to isolated nucleic acids, compositions, and kits useful for identifying adeno-associated viruses in cells. In some aspects, the invention provides kits and methods for producing somatic transgenic animal models using recombinant AAV (rAAV) to an animal having at least one transgene that expresses a small interfering nucleic acid or at least one binding site for a miRNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.